Literature DB >> 16756958

Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation.

M Antoine1, W Wirz, C G Tag, A M Gressner, M Wycislo, R Müller, P Kiefer.   

Abstract

Endothelial cells line the blood vessel and precursor endothelial cells appear to have a pivotal effect on the organ formation of the heart, the embryonic development of the kidney, and the liver. Several growth factors including the fibroblast growth factors (FGF) seem to be involved in these processes. Ligands such as basic FGF produced and secreted by endothelial cells may also coordinate cellular migration, differentiation, and proliferation under pathological conditions including wound healing, tumorgenesis, and fibrogenesis in the adult. Recently we demonstrated the expression of two secreted FGFs, FGF16, and FGF18, in HUVEC and in rat aortic tissue. In the present report, we confirmed by RT-PCR analysis that FGF18 is wildly expressed in the cardiovascular tissue, while FGF16 showed a more restricted expression pattern. HUVEC clearly demonstrated chemotaxis towards FGF16 and FGF18. Both FGFs also enhanced cell migration in response to mechanical damage. However, recombinant FGF16 and FGF18 failed to induce endothelial cell proliferation or sprouting in a three-dimensional in vitro angiogenesis assay. Fgf18 expression was earlier reported in the liver, and we detected FGF18 expression in liver vascular and liver sinusoidal endothelial cells (LSECs), but not in hepatic parenchymal cells. Recombinant FGF18 stimulated DNA synthesis in primary hepatocytes, suggesting, that endothelial FGF18 might have a paracrine function in promoting growth of the parenchymal tissue. Interestingly, FGF2, which is mitogenic on endothelial cells and hepatocytes stimulates a sustained MAPK activation in both cell types, while FGF18 causes a short transient activation of the MAPK pathway in endothelial cells but a sustained activation in hepatocytes. Therefore, the difference in the time course of MAPK activation by the different FGFs appears to be the cause for the different cellular responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756958     DOI: 10.1016/j.bbrc.2006.05.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Fibroblast growth factor signaling in the vasculature.

Authors:  Xuehui Yang; Lucy Liaw; Igor Prudovsky; Peter C Brooks; Calvin Vary; Leif Oxburgh; Robert Friesel
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

2.  FGF18 as a prognostic and therapeutic biomarker in ovarian cancer.

Authors:  Wei Wei; Samuel C Mok; Esther Oliva; Sung-hoon Kim; Gayatry Mohapatra; Michael J Birrer
Journal:  J Clin Invest       Date:  2013-09-09       Impact factor: 14.808

3.  FGF18 as a potential biomarker in serous and mucinous ovarian tumors.

Authors:  Saba El-Gendi; Eman Abdelzaher; Mohamed Farouk Mostafa; Ghada Abu Sheasha
Journal:  Tumour Biol       Date:  2015-10-02

4.  Embryonic coronary vasculogenesis and angiogenesis are regulated by interactions between multiple FGFs and VEGF and are influenced by mesenchymal stem cells.

Authors:  Robert J Tomanek; Lance P Christensen; Michael Simons; Masahiro Murakami; Wei Zheng; Gina C Schatteman
Journal:  Dev Dyn       Date:  2010-12       Impact factor: 3.780

5.  FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway.

Authors:  Moitri Basu; Satinath Mukhopadhyay; Uttara Chatterjee; Sib Sankar Roy
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

6.  The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

Authors:  Awatef Ben Jemaa; Sataa Sallami; Dunia Ramarli; Marco Colombatti; Ridha Oueslati
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

7.  Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.

Authors:  G Sonvilla; S Allerstorfer; C Heinzle; S Stättner; J Karner; M Klimpfinger; F Wrba; H Fischer; C Gauglhofer; S Spiegl-Kreinecker; B Grasl-Kraupp; K Holzmann; M Grusch; W Berger; B Marian
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

8.  FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart.

Authors:  Alina G Sofronescu; Karen A Detillieux; Peter A Cattini
Journal:  Cardiovasc Res       Date:  2010-01-22       Impact factor: 10.787

9.  Stimulatory Influences of Far Infrared Therapy on the Transcriptome and Genetic Networks of Endothelial Progenitor Cells Receiving High Glucose Treatment.

Authors:  Tzu-Chiao Lin; Chin-Sheng Lin; Tsung-Neng Tsai; Shu-Meng Cheng; Wei-Shiang Lin; Cheng-Chung Cheng; Chun-Hsien Wu; Chih-Hsueng Hsu
Journal:  Acta Cardiol Sin       Date:  2015-09       Impact factor: 2.672

10.  FGF-16 is released from neonatal cardiac myocytes and alters growth-related signaling: a possible role in postnatal development.

Authors:  Shun Yan Lu; David P Sontag; Karen A Detillieux; Peter A Cattini
Journal:  Am J Physiol Cell Physiol       Date:  2008-03-12       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.